NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,335 | -58.7% | 3,117 | 0.0% | 0.00% | – |
| Q2 2023 | $8,073 | -36.5% | 3,117 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $12,717 | -18.7% | 3,117 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $15,647 | -60.9% | 3,117 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $40,000 | +25.0% | 3,117 | +24.7% | 0.00% | +100.0% |
| Q2 2022 | $32,000 | -15.8% | 2,499 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $38,000 | -13.6% | 2,499 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $44,000 | -17.0% | 2,499 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $53,000 | +29.3% | 2,499 | +19.1% | 0.00% | +100.0% |
| Q2 2021 | $41,000 | -32.8% | 2,099 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $61,000 | -4.7% | 2,099 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $64,000 | +93.9% | 2,099 | 0.0% | 0.00% | +200.0% |
| Q3 2020 | $33,000 | -19.5% | 2,099 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $41,000 | +57.7% | 2,099 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $26,000 | -33.3% | 2,099 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $39,000 | +387.5% | 2,099 | +254.0% | 0.00% | – |
| Q3 2019 | $8,000 | -11.1% | 593 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | – | 593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $79,175,000 | 44.14% |
| Ponoi II Management, LLC | 1,298,908 | $27,303,000 | 40.46% |
| Column Group LLC | 15,396,116 | $323,626,000 | 36.81% |
| Ponoi Management, LLC | 1,298,908 | $27,303,000 | 24.24% |
| Euclidean Capital LLC | 832,274 | $17,494,000 | 8.50% |
| StepStone Group LP | 1,573,357 | $33,072,000 | 2.14% |
| Octagon Capital Advisors LP | 200,000 | $4,204,000 | 1.04% |
| Redmile Group, LLC | 2,505,118 | $52,658,000 | 0.92% |
| BVF INC/IL | 955,000 | $20,074,000 | 0.78% |
| Boxer Capital, LLC | 500,000 | $10,510,000 | 0.37% |